The Combination of Sorafenib With Transarterial Chemoembolisation for Hepatocellular Carcinoma Academic Article uri icon

abstract

  • Standard of practice involves using transarterial therapy for multifocal hepatocellular carcinoma (HCC) alone and sorafenib only for more advanced HCC, but the sorafenib and transarterial therapy combination may provide greater efficacy.

publication date

  • 2011-07-01